Join the 'Trazodone' group to help and get support from people like you.

Trazodone Blog

Psychiatric Drugs More Often Prescribed in the South

Posted 1 Feb 2013 by Drugs.com

FRIDAY, Feb. 1 – Use of psychiatric medications is most prevalent in the southern United States and least prevalent in the West, according to a new U.S. study. Although people living in the West are the least likely to use antipsychotics, antidepressants and stimulants, the Yale researchers found that the drugs' use is 40 percent higher in a large section of the South than in other parts of the country. The study authors attributed this discrepancy to variations in local access to health care and marketing efforts within the pharmaceutical industry. "The geographic patterns we identify are striking and map onto the patterns found for a host of other medical conditions and treatments, from cognitive decline to bypass surgery," Marissa King, assistant professor of organizational behavior at the Yale School of Management, said in a school news release. "Our work suggests that access to ... Read more

Related support groups: Depression, Bipolar Disorder, Adderall, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Seroquel, Celexa, Paxil, Phentermine, Trazodone, Vyvanse, Citalopram, Abilify, Pristiq, Lithium, Viibryd

No Proof Drugs Ease Kids' Migraines: Study

Posted 28 Jan 2013 by Drugs.com

MONDAY, Jan. 28 – Children and teens who get migraine headaches suffer in multiple ways, missing school and fun time with friends while waiting for the debilitating pain to subside. Now, two new broad reviews of pediatric migraine research point to a troubling conclusion: There is no clear evidence that drugs currently used to treat and prevent headaches among adults do anything much to help similarly afflicted children. The finding stems from a pediatric migraine-treatment investigation conducted by the U.S. Food and Drug Administration (FDA) and a pediatric migraine-prevention study out of the Medical College of Wisconsin in Milwaukee. The results of both analyses are published online Jan. 28 in JAMA Pediatrics. On the migraine prevention front, Wisconsin's Dr. Jeffrey Jackson, a professor of medicine, and colleagues reviewed 21 previously conducted studies (dating up to mid-2012) ... Read more

Related support groups: Migraine, Trazodone, Topamax, Topiramate, Topamax Sprinkle, Oleptro, Desyrel, Topiragen, Desyrel Dividose

Minorities, Medicare Recipients Less Likely to Get Antidepressants

Posted 9 Apr 2012 by Drugs.com

MONDAY, April 9 – Hispanics and blacks are less likely to be prescribed antidepressants than whites, and Medicare and Medicaid patients are less likely to receive the drugs than those with private insurance, a new study says. University of Michigan School of Public Health researchers examined data from 1993 to 2007 and found that whites were 1.5 times more likely to receive antidepressants than blacks or Hispanics with major depression. The study also found that Medicare and Medicaid patients were 31 percent and 38 percent less likely to be prescribed antidepressants than privately insured patients. Race didn't play a role in the type of antidepressants prescribed to patients, but insurance did. Medicare and Medicaid patients were 58 percent and 61 percent less likely to receive newer antidepressants than privately insured patients. Newer types of antidepressants such as serotonin ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Viibryd, Amitriptyline, Sertraline, Effexor XR, Bupropion, Fluoxetine, Venlafaxine, Savella

Fear of Antidepressants Keep Many From Disclosing Depression

Posted 13 Sep 2011 by Drugs.com

TUESDAY, Sept. 13 – For a nation that seems ready to pop a pill for any ill, a new study suggests that the opposite seems true for some people with symptoms of depression, whose concerns about the side effects of antidepressants were the top reason they wouldn't disclose warning signs to their doctors. A phone survey of more than 1,000 adults who had previously participated in the California Behavioral Risk Factor Survey System, which probed depression-related beliefs, showed that 43 percent reported one or more reasons for not talking to their primary care physician about their depression. Nearly a quarter of them worried that their doctor would recommend antidepressants – the most frequently cited reason for withholding the information. Other stated barriers to sharing depressive symptoms included the belief that it's not a primary care physician's job to deal with emotional issues ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Viibryd, Amitriptyline, Sertraline, Effexor XR, Bupropion, Fluoxetine, Venlafaxine, Savella

Antidepressant Use Rising as Psychotherapy Rates Fall

Posted 6 Dec 2010 by Drugs.com

MONDAY, Dec. 6 – Even as fewer Americans have sought psychotherapy for their depression, antidepressant prescription rates have continued to climb in recent years, a new survey reveals. "This is an encouraging trend as it suggests that fewer depressed Americans are going without treatment," said study author Dr. Mark Olfson, a professor of clinical psychiatry at Columbia University/New York State Psychiatric Institute in New York City. "At the same time, however, the decline in psychotherapy raises the possibility that many depressed patients are not receiving optimal care." "While progress is being made in increasing the availability of depression care, a mismatch is opening up between clinical evidence and practice," Olfson cautioned. "For many depressed adults and youth, a combination of psychotherapy and antidepressants is the most effective approach. Yet, only about one-third of ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Amitriptyline, Sertraline, Effexor XR, Bupropion, Fluoxetine, Venlafaxine, Savella, Wellbutrin XL

Labopharm Receives FDA Approval for Oleptro

Posted 3 Feb 2010 by Drugs.com

LAVAL, QC and PRINCETON, NJ, Feb. 3 /PRNewswire-FirstCall/ – Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Oleptro (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. Oleptro utilizes Contramid(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications. "Oleptro represents Labopharm's second Contramid(R) technology-based product to receive FDA approval in just over a year," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "We are excited about the opportunity for Oleptro and are preparing the product for launch into the $11 billion-plus U.S. antidepressant market. We are working towards finalizing a commercialization path for ... Read more

Related support groups: Depression, Trazodone

Antidepressant Use in U.S. Has Almost Doubled

Posted 16 Dec 2009 by Drugs.com

MONDAY, Aug. 3 – Antidepressant use among United States residents almost doubled between 1996 and 2005, along with a concurrent rise in the use of other psychotropic medications, a new report shows. The increase seemed to span virtually all demographic groups. "Over 10 percent of people over the age of 6 were receiving anti-depression medication. That strikes me as significant," said study author Dr. Mark Olfson, a professor of clinical psychiatry at Columbia University/New York State Psychiatric Institute in New York City. According to background information in the study, antidepressants are now the most widely prescribed class of drugs in the United States. The expansion in use dates back to the 1980s, with the introduction of the antidepressant Prozac (fluoxetine). The study found that 5.84 percent of U.S. residents aged 6 and over were using antidepressants in 1996, compared with ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Amitriptyline, Sertraline, Effexor XR, Bupropion, Fluoxetine, Venlafaxine, Savella, Wellbutrin XL

Psych Drugs Gaining Widespread Acceptance

Posted 16 Dec 2009 by Drugs.com

FRIDAY, July 31 – A growing number of Americans now have a positive opinion on psychiatric medications, a new study contends. About five out of six people surveyed felt psychiatric medications could help people control psychiatric symptoms, but many also expected the medications could help people deal with day-to-day stresses, help them feel better about themselves and make things easier with family and friends. "People's attitudes regarding psychiatric medications became more favorable between 1998 and 2006," said study author Dr. Ramin Mojtabai, an associate professor in the department of mental health at Johns Hopkins Bloomberg School of Public Health in Baltimore. Mojtabai expressed concern, however, that people's attitudes were increasingly positive, even in situations where there might not be a proven benefit to the drugs. "My hope would be for people to be more discriminating in ... Read more

Related support groups: Anxiety, Depression, Generalized Anxiety Disorder, Panic Disorder, Bipolar Disorder, Insomnia, Anxiety and Stress, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Obsessive Compulsive Disorder, Trazodone, Citalopram, Pristiq, Social Anxiety Disorder

Psychotropic Medications Associated With Risk of Falls in Older Adults

Posted 1 Dec 2009 by Drugs.com

CHICAGO, Nov. 23, 2009 - Older adults who take several types of psychotropic medications—such as antidepressants or sedatives—appear more likely to experience falls, according to an analysis of previous studies reported in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. More than 30 percent of individuals older than 65 will fall at least once a year, and falls and their complications are the fifth-leading cause of death in the developed world, according to background information in the article. Each year, 85 percent of all injury-related hospital admissions and more than 40 percent of nursing home admissions are related to falls, and the annual costs related to falls and their complications are estimated to be in the billions of dollars worldwide. Both internal and external risk factors contribute to falls, and medications have previously been i ... Read more

Related support groups: Xanax, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Klonopin, Celexa, Paxil, Clonazepam, Ambien, Trazodone, Valium, Ativan, Citalopram, Pristiq, Amitriptyline, Sertraline, Alprazolam

Ask a Question

Further Information

Related Condition Support Groups

Insomnia, Anxiety, Sedation, Fibromyalgia, Depression, Major Depressive Disorder, Reflex Sympathetic Dystrophy Syndrome, Headache

Related Drug Support Groups

Oleptro, Desyrel, Desyrel Dividose

Trazodone Patient Information at Drugs.com